EP2694959
BIOMARKERS FOR PREDICTING SENSITIVITY TO CANCER TREATMENTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.3.2012EP published:
13.11.2019EP application number:
12765178.4
EPO information:
European Patent Register
Max expiry date:
29.3.2032
Title:
BIOMARKERS FOR PREDICTING SENSITIVITY TO CANCER TREATMENTS
Timeline
Today
30.3.2012EP application
13.11.2019EP Publication
Owner
Name:
Genentech, Inc.Address:
1 DNA Way, 94080-4990, South San Francisco, CA, US
Inventor
Name:
LIN, KuiAddress:
South San FranciscoCalifornia, US
Name:
PUNNOOSE, ElizabethAddress:
South San FranciscoCalifornia, US
Name:
SESHAGIRI, SomasekarAddress:
South San FranciscoCalifornia, US
Priority
Number:
201161471036 PDate:
1.4.2011Country:
US
Classification
Categories:
C12Q 1/6886, A61K 31/517, A61K 31/58